Search

  • Select Article Type
  • Abstract Supplements
  • Ashish Testing
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • Case Study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • Conference Report
  • Congress Report
  • Correction
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • Mini Review
  • News
  • Obituary
  • original-paper
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • Review Article
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Journal Of Ultrasonography

 

Review

The role of ultrasound and lymphoscintigraphy in the assessment of axillary lymph nodes in patients with breast cancer

Breast cancer is the most common malignancy and the leading cause of death due to cancer in European women. Mammography screening programs aimed to increase the detection of early cancer stages were implemented in numerous European countries. Recent data show a decrease in mortality due to breast cancer in many countries, particularly among young women. At the same time, the number of sentinel node biopsy procedures and breast-conserving surgeries has increased. Intraoperative sentinel lymph

Michał Nieciecki, Katarzyna Dobruch-Sobczak, Paweł Wareluk, Anna Gumińska, Ewa Białek, Marek Cacko, Leszek Królicki

Journal of Ultrasonography , ISSUE 64, 5–15

original-paper

Monitoring the response to neoadjuvant chemotherapy in patients with breast cancer using ultrasound scattering coefficient: A preliminary report

Introduction Neoadjuvant chemotherapy (NAC) was initially used in locally advanced breast cancer (LABC) and the inflammatory form of cancer to downstage locally inoperable disease. Currently, it is recommended for patients with Stage 3 and with early-stage disease with HER-2 (human epidermal growth factor receptors positive or triple-negative (TNBC) breast cancer(1,2). NAC reduces the tumor mass by inducing intracellular damage, which causes cell death and degeneration. Response to treatment

Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Ziemowit Klimoda, Wojciech Secomski, Piotr Karwat, Ewa Markiewicz-Grodzicka, Agnieszka Kolasińska-Ćwikła, Katarzyna Roszkowska-Purska, Jerzy Litniewski

Journal of Ultrasonography , ISSUE 77, 89–97

Review

Breast ultrasound scans – surgeons’ expectations

Piotr Bednarski, Katarzyna Dobruch-Sobczak, Eryk Chrapowicki, Wiesław Jakubowski

Journal of Ultrasonography , ISSUE 61, 164–171

No Record Found..
Page Actions